Asia Pacific PARP Inhibitor Biomarkers Market Size, Share & Trends Analysis Report By Product (Kits, and Assays), By Application, By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, and Others), By Country and Growth Forecast, 2024 - 2031

The Asia Pacific PARP Inhibitor Biomarkers Market would witness market growth of 8.9% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific PARP Inhibitor Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $109.1 Million by 2031. The Japan market is registering a CAGR of 8.2% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 9.6% during (2024 - 2031).

The adoption of this in clinical practice and research settings has been steadily increasing, driven by several factors that highlight their importance in personalized cancer care and precision medicine. For example, clinical practice guidelines from reputable organizations, such as the National Comprehensive Cancer Network (NCCN).

Additionally, the market is witnessing several notable trends that reflect the evolving landscape of precision oncology and personalized cancer care. These trends encompass advancements in biomarker discovery, technological innovations in biomarker testing, shifts in clinical practice guidelines, and the emergence of novel therapeutic strategies.

As the hospital sector in India expands, there is increased access to healthcare services, including diagnostic facilities and specialized testing laboratories. This expansion facilitates greater access to biomarker testing services, including it, for patients nationwide. Patients visiting hospitals for cancer treatment may undergo biomarker testing to determine their eligibility for targeted therapies such as these, leading to increased demand for biomarker testing services.

Free Valuable Insights: The Global PARP Inhibitor Biomarkers Market is Predict to reach USD 1.6 Billion by 2031, at a CAGR of 8.3%

Based on Product, the market is segmented into Kits, and Assays. Based on Application, the market is segmented into Breast Cancer, Ovarian Cancer, and Others. Based on Services, the market is segmented into BRCA 1 & 2 Testing, HRD Testing, HRR Testing, and Others.Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Myriad Genetics, Inc.
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• NeoGenomics Laboratories
• Qiagen N.V
• Agilent Technologies, Inc.
• Merck KGaA
• Bayer AG
• AstraZeneca PLC
• GlaxoSmithKline PLC (GSK)

Asia Pacific PARP Inhibitor Biomarkers Market Report Segmentation

By Product

• Kits
• Assays

By Application

• Breast Cancer
• Ovarian Cancer
• Others

By Services

• BRCA 1 & 2 Testing
• HRD Testing
• HRR Testing
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific PARP Inhibitor Biomarkers Market, by Product
1.4.2 Asia Pacific PARP Inhibitor Biomarkers Market, by Application
1.4.3 Asia Pacific PARP Inhibitor Biomarkers Market, by Services
1.4.4 Asia Pacific PARP Inhibitor Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Asia Pacific PARP Inhibitor Biomarkers Market by Product
4.1 Asia Pacific Kits Market by Country
4.2 Asia Pacific Assays Market by Country

Chapter 5. Asia Pacific PARP Inhibitor Biomarkers Market by Application
5.1 Asia Pacific Breast Cancer Market by Country
5.2 Asia Pacific Ovarian Cancer Market by Country
5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific PARP Inhibitor Biomarkers Market by Services
6.1 Asia Pacific BRCA 1 & 2 Testing Market by Country
6.2 Asia Pacific HRD Testing Market by Country
6.3 Asia Pacific HRR Testing Market by Country
6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific PARP Inhibitor Biomarkers Market by Country
7.1 China PARP Inhibitor Biomarkers Market
7.1.1 China PARP Inhibitor Biomarkers Market by Product
7.1.2 China PARP Inhibitor Biomarkers Market by Application
7.1.3 China PARP Inhibitor Biomarkers Market by Services
7.2 Japan PARP Inhibitor Biomarkers Market
7.2.1 Japan PARP Inhibitor Biomarkers Market by Product
7.2.2 Japan PARP Inhibitor Biomarkers Market by Application
7.2.3 Japan PARP Inhibitor Biomarkers Market by Services
7.3 India PARP Inhibitor Biomarkers Market
7.3.1 India PARP Inhibitor Biomarkers Market by Product
7.3.2 India PARP Inhibitor Biomarkers Market by Application
7.3.3 India PARP Inhibitor Biomarkers Market by Services
7.4 South Korea PARP Inhibitor Biomarkers Market
7.4.1 South Korea PARP Inhibitor Biomarkers Market by Product
7.4.2 South Korea PARP Inhibitor Biomarkers Market by Application
7.4.3 South Korea PARP Inhibitor Biomarkers Market by Services
7.5 Singapore PARP Inhibitor Biomarkers Market
7.5.1 Singapore PARP Inhibitor Biomarkers Market by Product
7.5.2 Singapore PARP Inhibitor Biomarkers Market by Application
7.5.3 Singapore PARP Inhibitor Biomarkers Market by Services
7.6 Malaysia PARP Inhibitor Biomarkers Market
7.6.1 Malaysia PARP Inhibitor Biomarkers Market by Product
7.6.2 Malaysia PARP Inhibitor Biomarkers Market by Application
7.6.3 Malaysia PARP Inhibitor Biomarkers Market by Services
7.7 Rest of Asia Pacific PARP Inhibitor Biomarkers Market
7.7.1 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product
7.7.2 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application
7.7.3 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services

Chapter 8. Company Profiles
8.1 Myriad Genetics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segment and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Neogenomics, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Qiagen N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Merck KGaA
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 AstraZeneca PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. GlaxoSmithKline PLC (GSK)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

TABLE 1 Asia Pacific PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 4 Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Kits Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Kits Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Assays Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Assays Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 10 Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 18 Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 19 Asia Pacific BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 20 Asia Pacific BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 21 Asia Pacific HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 22 Asia Pacific HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 23 Asia Pacific HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 24 Asia Pacific HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 27 Asia Pacific PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 29 China PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 30 China PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 31 China PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 32 China PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 33 China PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 34 China PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 35 China PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 36 China PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 37 Japan PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 38 Japan PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 39 Japan PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 40 Japan PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 41 Japan PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 42 Japan PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 43 Japan PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 44 Japan PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 45 India PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 46 India PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 47 India PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 48 India PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 49 India PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 50 India PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 51 India PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 52 India PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 53 South Korea PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 54 South Korea PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 55 South Korea PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 56 South Korea PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 57 South Korea PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 58 South Korea PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 59 South Korea PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 60 South Korea PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 61 Singapore PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 62 Singapore PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 63 Singapore PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 64 Singapore PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 65 Singapore PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 66 Singapore PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 67 Singapore PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 68 Singapore PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 69 Malaysia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 70 Malaysia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 71 Malaysia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 72 Malaysia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 73 Malaysia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 74 Malaysia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 75 Malaysia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 76 Malaysia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 77 Rest of Asia Pacific PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 78 Rest of Asia Pacific PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 79 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 80 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 81 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 82 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 83 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 84 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 85 Key Information – Myriad Genetics, Inc.
TABLE 86 Key Information – Thermo Fisher Scientific, Inc.
TABLE 87 key information – Illumina, Inc.
TABLE 88 Key Information – neogenomics, inc.
TABLE 89 Key Information – Qiagen N.V.
TABLE 90 key Information – Agilent Technologies, Inc.
TABLE 91 key Information – Merck KGaA
TABLE 92 Key Information – Bayer AG
TABLE 93 Key Information – AstraZeneca PLC
TABLE 94 Key Information – GlaxoSmithKline PLC

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific PARP Inhibitor Biomarkers Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting PARP Inhibitor Biomarkers Market
FIG 4 Porter’s Five Forces Analysis – PARP Inhibitor Biomarkers Market
FIG 5 Asia Pacific PARP Inhibitor Biomarkers Market share by Product, 2023
FIG 6 Asia Pacific PARP Inhibitor Biomarkers Market share by Product, 2031
FIG 7 Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2020 - 2031, USD Million
FIG 8 Asia Pacific PARP Inhibitor Biomarkers Market share by Application, 2023
FIG 9 Asia Pacific PARP Inhibitor Biomarkers Market share by Application, 2031
FIG 10 Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2020 - 2031, USD Million
FIG 11 Asia Pacific PARP Inhibitor Biomarkers Market share by Services, 2023
FIG 12 Asia Pacific PARP Inhibitor Biomarkers Market share by Services, 2031
FIG 13 Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2020 - 2031, USD Million
FIG 14 Asia Pacific PARP Inhibitor Biomarkers Market share by Country, 2023
FIG 15 Asia Pacific PARP Inhibitor Biomarkers Market share by Country, 2031
FIG 16 Asia Pacific PARP Inhibitor Biomarkers Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 18 Swot Analysis: Illumina, Inc.
FIG 19 Swot Analysis: Qiagen N.V.
FIG 20 Swot Analysis: Agilent Technologies, Inc.
FIG 21 Swot Analysis: Merck KGaA
FIG 22 Swot Analysis: Bayer AG
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 SWOT Analysis: GlaxoSmithKline PLC